NCT07293754 2026-02-17
RaPTR-101
Repertoire Immune Medicines
Phase 1/2 Recruiting
Clinical Trials
8 trialsNCT07126665 2025-11-18
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT07192107 2025-09-25
A Study of MHB042C in Patients With Advanced Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT07050641 2025-07-04
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Sinocelltech Ltd.
Phase 1/2 Recruiting
NCT07045454 2025-07-01
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1 Recruiting
NCT05477849 2025-04-01
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
Virogin Biotech Ltd.
Phase 1 Recruiting
NCT06592417 2024-09-19
To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
NCT04165590 2024-02-20
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
CAS Lamvac Biotech Co., Ltd.
Phase 1/2 Recruiting